The new standard in heart failure management
Non-invasive and scalable solution to support healthcare professionals with managing intracardiac pressures
Accurate, absolute, and actionable values of the intracardiac pressures can help healthcare professionals reduce the burden of heart failure.
Intracardiac pressures as a way of understanding and managing heart failure
The SAVE Sensor System
Leveraging a novel combination of Seismic, Acoustic, Visual and Electrocardiographic sensors for estimating the intracardiac pressures
State-of-the-art machine learning
Built on Acorai’s proprietary datasets and data partnerships with world-leading hospitals
Handheld and portable form factor
A non-invasive format with an intuitive interface will integrate easily into daily practice
Accurate, absolute & actionable non-invasive intracardiac pressure monitoring
Accurate
The objective of the Acorai Heart Monitor is to offer accurate estimations of pulmonary pressure to support personalized heart failure treatment
Absolute
The Save Sensor System is a first-of-its-kind hardware architecture and machine learning with absolute intracardiac insights in mind.
Actionable
An ongoing clinical study (CAPTURE-HF) aims to confirm if the monitor can deliver actionable information equal to invasive methods.
Acorai is working to enable data that can alleviate healthcare burdens
Readmission rates & penalties
Ensuring that patients are stable prior to discharge reduced reamission rates
Length of stay
A better understanding of patient stability enables better discarge decisions
Complications
Continuous monitoring improves medication decisions and patient stability
As demonstrated by LAPTOP-HF, COMPASS-HF, PARADIGM-HF, CHAMPION TRIAL, GUIDE-HF & MONITOR-HF
Working with world-leading partners to drive meaningful change
Cedars-Sinai is ranked #2 in the US, investing in, and supporting the growth of companies focused on improving healthcare and healthcare delivery.
Mayo Clinic Platform Accelerate invests in startups and helps develop, enhance, and test their AI models with Mayo Clinic Platform’s rich data sets.
EIC invests in companies with innovative, game-changing products, services or business models that could create new markets or disrupt existing ones.
HeartX is a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials.
Royal Brompton Hospital is the largest specialist heart & lung medical centre in the United Kingdom. Managed by Guy’s & St Thomas’ NHS Foundation Trust.
Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, technology-based companies.
Saint Luke’s Health System consists of 16 area hospitals and campuses and several primary and specialty care practices, and provides a range of inpatient
Bayer AG is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world.
The Västra Götaland region works to stimulate research in healthcare in collaboration with universities and business.
Life Science Invest has so far invested in 20 life science companies. In the coming year, it is intended to invest with a focus on companies in the start-up phase.
KHP Ventures is a King’s College London, King’s College Hospital NHS Foundation Trust & Guy’s and St Thomas’ Hospital NHS Foundation Trust collaboration.
EIT Health Gold Track program helps the brightest minds to explore new ideas & find practical resources to create products & services rooted in innovation.
Saint Luke’s Health System consists of 16 area hospitals and campuses and several primary and specialty care practices, and provides a range of inpatient
Bayer AG is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world.
The Västra Götaland region works to stimulate research in healthcare in collaboration with universities and business.
Life Science Invest has so far investedin 20 life science companies. In the coming year, it is intended to invest with a focus on companies in the start-up phase.
KHP Ventures is a King’s College London, King’s College Hospital NHS Foundation Trust & Guy’s and St Thomas’ Hospital NHS Foundation Trust collaboration.
EIT Health Gold Track program helps the brightest minds to explore new ideas & find practical resources to create products & services rooted in innovation.
Explore our latest news and insights
Help us transform heart failure management
Follow our journey!
